Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sony Corp, Olympus Delay Medical Venture As Regulatory Approval On Hold-Reuters


Friday, 29 Mar 2013 02:32am EDT 

Reuters reported that Sony Corp and Olympus Corp have again delayed the start of a joint venture (JV) to develop medical equipment because they have yet to gain approval from some regulators. Plans by the Japanese companies to establish a joint venture to design and build medical devices have struggled to win approval in China, according to a source at one of the corporations familiar with the matter. Neither Sony or Olympus have said where they are still awaiting permission from regulators. 

Company Quote

18.86
0.03 +0.16%
22 Aug 2014